Why the US Centers for Medicare and Medicaid Services (CMS) should have required a randomized trial of Foundation Medicine (F1CDx) before paying for it

Research output: Contribution to journalEditorial

10 Scopus citations
Original languageEnglish (US)
Pages (from-to)298-300
Number of pages3
JournalAnnals of Oncology
Volume29
Issue number2
DOIs
StatePublished - Feb 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this